Johnson & Johnson Stock Latest News

Janssen Pharmaceuticals, the wholly-owned subsidiary of Johnson & Johnson (JNJ), has bagged the U.S. Food and Drug Administration’s (FDA)...

Janssen, a Johnson & Johnson (JNJ) company, announced that the U.S. Food and Drug Administration (FDA) has approved...

Johnson & Johnson (JNJ) is one of just two AAA-rated companies in the world, the other one being...

Global pharmaceutical, medical devices and consumer goods conglomerate Johnson & Johnson (JNJ) has reported robust second-quarter 2021 financial...

Drugmaker Johnson & Johnson (JNJ) is planning to place liabilities from the Baby Powder litigation into a newly...

It’s a smart move to add a few high-quality dividend stocks to one’s portfolio. Besides diversification, dividend-paying companies...

Johnson & Johnson (JNJ) recently announced that it is retracting every unit of five NEUTROGENA and AVEENO aerosol...

According to a report by CNA, the U.S. Food and Drug Administration (FDA) has issued updated warning labels...

According to a report by CNN, the U.S. Food and Drug Administration (FDA) has issued a warning that...

Drugmaker Johnson & Johnson (JNJ) announced that its single-dose COVID-19 vaccine has shown success against the Delta variant...

Drugmaker Johnson & Johnson (JNJ) announced that it has reached a settlement with the State of New York...

Johnson & Johnson Vision (JNJ) has received approval in the US for TECNIS Synergy and TECNIS Synergy Toric...

Johnson & Johnson is slated to report first-quarter 2021 earnings on April 20 before the market opens. Over...

By now you’ve heard the news. On Tuesday, April 13, the U.S. Centers for Disease Control and Food...

Pulmatrix is poised to regain full rights to its narrow spectrum kinase inhibitor (NSKI), including PUR1800. Johnson &...

Cidara Therapeutics has entered into a worldwide licensing and collaboration deal with Janssen Pharmaceuticals, a unit of Johnson...

Janssen Pharmaceutica NV, a Johnson & Johnson company has inked a deal with the African Vaccine Acquisition Trust...

Janssen, a Johnson & Johnson (JNJ) company, announced that the US Food and Drug Administration (FDA) has approved...

Johnson & Johnson’s single-dose COVID-19 vaccine, which was developed by the Janssen Pharmaceutical Companies of Johnson & Johnson...

Johnson & Johnson’s single-dose COVID-19 vaccine has been authorized for emergency use by the US Food and Drug...

Johnson & Johnson has submitted an application to the US Food and Drug Administration (FDA) for emergency use...

Johnson & Johnson announced that it is likely to release the Phase 3 trial results of its Covid-19...

Scientists and government sources claimed today that Johnson & Johnson’s single-jab COVID-19 vaccine could be given emergency use...

Generally, companies in the healthcare sector show resilience amid challenging macro conditions. However, certain healthcare stocks have been...

Johnson & Johnson expects to have all the data needed to seek U.S. authorization for its experimental COVID-19...

Johnson & Johnson said that it has kicked off a Phase 3 clinical trial in the UK to...

Voting in the U.S. presidential election is over and the world eagerly waits to see whether incumbent president...

Johnson & Johnson has struck a preliminary agreement with Aspen Pharmacare Holdings to manufacture its Covid-19 vaccine candidate...

Johnson & Johnson announced on Friday that it is preparing to resume the Phase 3 US trial of...

It has been an action-packed week so far for pharma giant Johnson & Johnson (JNJ). On Tuesday, the...

Johnson & Johnson said it will contribute up to an additional $1 billion for a potential settlement agreement...

Johnson & Johnson (JNJ) has halted its late-stage Covid-19 vaccine trial after a study participant fell ill, news...

Johnson & Johnson said Monday that its Tremfya drug induced clinical and endoscopic improvements in adult patients with...

Johnson & Johnson said that Phase1/2 trial data showed that a single dose of its COVID-19 vaccine candidate,...

Johnson & Johnson shares are up 2.3% in Wednesday’s pre-market trading after the healthcare company announced that it...

Johnson & Johnson will kick off Phase 2 trials of its COVID-19 vaccine candidate in Spain on Monday,...

Johnson & Johnson announced Tuesday that the European Commission (EC) has approved an extended use of imbruvica (ibrutinib)...

Johnson & Johnson and Pfizer have been in the news for the development of potential vaccines for COVID-19....

The U.S. Food and Drug Administration (FDA) has approved the use of Johnson & Johnson’s (JNJ) Darzalex (daratumumab) with...

Johnson & Johnson (JNJ) is aiming to test its coronavirus vaccine in up to 60,000 volunteers in a...

Johnson & Johnson (JNJ) has agreed to buy Momenta Pharma (MNTA), a biotech focused on discovering and developing...

The European Commission announced Thursday that it has concluded exploratory talks with US pharmaceutical company Johnson & Johnson...

The race to be first to market with a COVID-19 vaccine is changing gears. As the companies developing...

Johnson & Johnson (JNJ) initiated first-in-human safety trials of its COVID-19 vaccine candidate after a single dose in...

The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers...

Johnson & Johnson (JNJ) exceeded analysts’ profit and sales expectations in the second quarter and lifted its earnings...

Emergent BioSolutions (EBS) has announced a 5-year agreement with Janssen Pharma, of Johnson & Johnson (JNJ), for large-scale...

Johnson & Johnson’s (JNJ) bid to toss out a jury verdict in favor of women who blamed their...

The European Commission is reportedly in advanced talks with Johnson & Johnson (JNJ) to purchase up-front doses of...

Johnson & Johnson (JNJ) said on Wednesday that it will start human trials of its COVID-19 vaccine as...